Theodoros Kyriakides

Medicine & Life Sciences

1. Age of Onset 33%
2. Amyloid 36%
3. Amyloid Neuropathies 21%
4. Amyloidosis, Hereditary, Transthyretin-Related 19%
5. Amyotrophic Lateral Sclerosis 19%
6. Amyotrophic lateral sclerosis 1 25%
7. Angelman Syndrome 18%
8. Antibodies 16%
9. Biopsy 32%
10. Charcot-Marie-Tooth Disease 32%
11. Chromosomes 23%
12. Chromosomes, Human, Pair 13 16%
13. Creatine Kinase 17%
14. Cyprus 100%
15. Duchenne Muscular Dystrophy 27%
16. Dystonic Disorders 17%
17. Dystrophin 19%
18. Dystrophin-Associated Proteins 21%
19. Electron Microscopy 40%
20. Familial Amyloid Neuropathies 19%
21. Genes 32%
22. Glycine-tRNA Ligase 23%
23. Glycogen Storage Disease Type V 20%
24. Hypoventilation 16%
25. Lipoprotein Receptors 17%
26. Mitochondrial Encephalomyopathies 67%
27. Multiple Sclerosis 39%
28. Muscle Form Glycogen Phosphorylase 23%
29. Muscles 60%
30. Muscular Diseases 47%
31. Muscular Dystrophies 22%
32. Mutation 51%
33. Myalgia 27%
34. Myasthenia Gravis 36%
35. Neuronopathy, Distal Hereditary Motor, Type V 31%
36. Penetrance 18%
37. Phenotype 29%
38. Phytanic Acid 20%
39. Plasma Exchange 22%
40. Polyneuropathies 27%
41. Population 21%
42. Prealbumin 51%
43. Refsum Disease 21%
44. Restless Legs Syndrome 16%
45. Sarcoglycans 19%
46. Sarcolemma 16%
47. Spinal Muscular Atrophies of Childhood 18%
48. Spinal Muscular Atrophy 57%
49. Transgenic Mice 25%
50. Vestibular Evoked Myogenic Potentials 64%